NUTRA PHARMA CORP. (NPHC) Total liabilities 2016–2025
NUTRA PHARMA CORP. (NPHC) total liabilities at each fiscal year-end, per SEC filings.
$17.4MFY2025 · since FY2016: $4.7M → $17.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.4M | +13.2% |
| FY2024 | $15.4M | +6.9% |
| FY2023 | $14.4M | +9.7% |
| FY2022 | $13.1M | -39.4% |
| FY2021 | $21.7M | +83.6% |
| FY2020 | $11.8M | -2.0% |
| FY2019 | $12.0M | +98.1% |
| FY2018 | $6.1M | +4.8% |
| FY2017 | $5.8M | +23.6% |
| FY2016 | $4.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice